Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Collaboration revenue $ 36,850 $ 62,071 $ 110,550 $ 287,190
Operating expenses:        
Research and development 2,409,471 5,648,952 9,972,055 16,320,090
General and administrative 1,542,689 2,280,345 5,330,967 6,259,494
Total operating expenses 3,952,160 7,929,297 15,303,022 22,579,584
Loss from operations (3,915,310) (7,867,226) (15,192,472) (22,292,394)
Foreign exchange (loss) gain (31,432) (9,794) 36,517 5,894
Net loss $ (3,946,742) $ (7,877,020) $ (15,155,955) $ (22,286,500)
Per share information:        
Net loss per share, basic $ (0.13) $ (1.82) $ (0.86) $ (5.17)
Net loss per share, diluted $ (0.13) $ (1.82) $ (0.86) $ (5.17)
Weighted average shares outstanding, basic 29,376,018 4,330,489 17,568,549 4,314,635
Weighted average shares outstanding, diluted 29,376,018 4,330,489 17,568,549 4,314,635